A chemically-modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A chemically-modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 11, Issue 6, Pages 1128-1136
Publisher
Wiley
Online
2013-04-13
DOI
10.1111/jth.12249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversal of antithrombotic agents
- (2012) Kenneth A. Bauer AMERICAN JOURNAL OF HEMATOLOGY
- A Case Series of Recombinant Platelet Factor 4 for Heparin Reversal After Cardiopulmonary Bypass
- (2012) Linda Demma et al. ANESTHESIA AND ANALGESIA
- Treatment and Prevention of Heparin-Induced Thrombocytopenia
- (2012) Lori-Ann Linkins et al. CHEST
- Heparin-Induced Thrombocytopenia: An Update
- (2012) Margaret Prechel et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Protamine sulfate stimulates degradation of factor Xa and the factor Xa–antithrombin complex
- (2011) Martin H Coggin et al. BLOOD COAGULATION & FIBRINOLYSIS
- Muscle Creatine Kinase Deficiency Triggers Both Actin Depolymerization and Desmin Disorganization by Advanced Glycation End Products in Dilated Cardiomyopathy
- (2011) Nicolas Diguet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery
- (2011) A. M. Yusuf et al. THROMBOSIS AND HAEMOSTASIS
- Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature
- (2011) J. Elmer et al. TRANSFUSION MEDICINE
- Reply to “A comment on laboratory monitoring of new anticoagulants”
- (2010) Donna D. Castellone et al. AMERICAN JOURNAL OF HEMATOLOGY
- Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives
- (2010) E. P. Bianchini et al. BLOOD
- Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist
- (2010) Daniel J. Cushing et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Reaction of the Butter Flavorant Diacetyl (2,3-Butanedione) withN-α-Acetylarginine: A Model for Epitope Formation with Pulmonary Proteins in the Etiology of Obliterative Bronchiolitis
- (2010) James M. Mathews et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke
- (2010) Mohamed Salem et al. THROMBOSIS AND HAEMOSTASIS
- Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation
- (2009) F. Ni Ainle et al. BLOOD
- Protamine inhibits formation of the covalent factor IXa–anti-thrombin complex
- (2009) Arthur S Brecher et al. BLOOD COAGULATION & FIBRINOLYSIS
- Effect of citrullination on the function and conformation of antithrombin
- (2009) A. Ordóñez et al. FEBS Journal
- Serious Anaphylactic Reactions due to Protamine Sulfate: A Systematic Literature Review
- (2008) Mads Nybo et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors
- (2008) T. ABSHIRE et al. HAEMOPHILIA
- Outbreak of Adverse Reactions Associated with Contaminated Heparin
- (2008) David B. Blossom et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now